13F filer · CIK 2012383 ↗
BlackRock
You are looking at Q1 2018. See the latest, Q2 2026 →
Reported value
$2.09T
−0.5% on the quarter before
Positions
4,974
227 new · 230 sold out
Top 10
13.7%
of the value
Est. gain
−$24.51B
on stocks held all quarter
Est. return
−1.2%
on those stocks since Q4 2017
Positions as of Mar 31, 2018, from BlackRock's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 23% of the reported value, each sized by its share, colored by what the fund did with it since Q4 2017. Striped tiles are options.
Largest buys
Since Q4 2017, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Booking Hldgs Inc~$6.45BNew · 0.0% → 0.3%+3,099,555 shares
- Worldpay Inc~$1.26BNew · 0.0% → 0.1%+15,311,688 shares
- Johnson & Johnson~$1.01BAdded · 1.1% → 1.1%+7,853,141 shares
- Ishares Tr~$992.6MAdded · 0.1% → 0.1%+20,558,319 shares
- Amazon~$971.8MAdded · 1.4% → 1.7%+671,415 shares
- Alibaba~$837.2MAdded · 0.5% → 0.5%+4,561,249 shares
- Ishares Tr~$629.2MAdded · 0.2% → 0.2%+9,980,872 shares
- Encompass Health Corp~$622.2MNew · 0.0% → 0.0%+10,883,027 shares
- Ishares Inc~$601.8MAdded · 0.1% → 0.1%+10,304,226 shares
- Microsoft~$592.2MAdded · 2.0% → 2.2%+6,488,089 shares
Largest sells
Since Q4 2017, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Priceline Grp Inc~$5.31BSold out · 0.3% → 0.0%−3,057,670 shares
- Powershares Qqq TrustCALL~$1.01BSold out · 0.0% → 0.0%−6,500,000 underlying
- Nektar Therapeutics~$739.6MCut · 0.1% → 0.1%−6,960,380 shares
- SPDR S&P 500 ETF TrCALL~$700.7MCut · 0.3% → 0.2%−2,662,700 underlying
- Lockheed Martin Corp~$696.7MCut · 0.3% → 0.3%−2,061,742 shares
- Ishares Tr~$666.6MCut · 0.3% → 0.3%−9,566,999 shares
- Vantiv Inc~$663.7MSold out · 0.0% → 0.0%−9,023,249 shares
- Cme Group Inc~$636.6MCut · 0.2% → 0.2%−3,936,056 shares
- Ishares TrPUT~$591.0MSold out · 0.0% → 0.0%−8,405,200 underlying
- Bioverativ Inc~$584.8MSold out · 0.0% → 0.0%−10,845,635 shares
Holdings
As of Mar 31, 2018. Changes are in shares against Dec 31, 2017, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AppleCOM · shares +0.2% · price −0.9% | 2.6% | $53.74B | −$463.6M | ||||||||
| MicrosoftCOM · shares +1.3% · price +6.7% | 2.2% | $45.62B | +$2.83B | ||||||||
| AmazonCOM · shares +2.7% · price +23.8% | 1.7% | $36.48B | +$6.82B | ||||||||
| Jpmorgan Chase & CoCOM · shares +0.7% · price +2.8% | 1.2% | $25.08B | +$686.1M | ||||||||
| MetaCL A · shares +2.0% · price −9.4% | 1.1% | $23.83B | −$2.44B | ||||||||
| Johnson & JohnsonCOM · shares +4.7% · price −8.3% | 1.1% | $22.48B | −$1.94B | ||||||||
| Berkshire Hathaway Inc DelCL B NEW · shares +1.8% · price +0.6% | 1.00% | $20.91B | +$129.7M | ||||||||
| Bank Amer CorpCOM · shares −0.8% · price +1.6% | 0.95% | $19.85B | +$311.1M | ||||||||
| AlphabetCAP STK CL C · shares +1.9% · price −1.4% | 0.94% | $19.68B | −$273.5M | ||||||||
| Exxon Mobil CorpCOM · shares +1.2% · price −10.8% | 0.93% | $19.46B | −$2.33B | ||||||||
| AlphabetCAP STK CL A · shares +1.5% · price −1.5% | 0.93% | $19.43B | −$300.2M | ||||||||
| Pfizer IncCOM · shares +1.5% · price −2.0% | 0.78% | $16.31B | −$330.5M | ||||||||
| IntelCOM · shares +1.8% · price +12.8% | 0.75% | $15.66B | +$1.75B | ||||||||
| Wells Fargo Co NewCOM · shares +0.9% · price −13.6% | 0.72% | $15.15B | −$2.37B | ||||||||
| CiscoCOM · shares +1.1% · price +12.0% | 0.70% | $14.54B | +$1.54B | ||||||||
| Unitedhealth Group IncCOM · shares −1.6% · price −2.9% | 0.69% | $14.44B | −$435.8M | ||||||||
| Visa Inc.COM CL A · shares −0.2% · price +4.9% | 0.69% | $14.36B | +$672.1M | ||||||||
| Chevron Corp NewCOM · shares −2.4% · price −8.9% | 0.68% | $14.30B | −$1.40B | ||||||||
| AT&TCOM · shares +2.8% · price −8.3% | 0.66% | $13.81B | −$1.22B | ||||||||
| Verizon Communications IncCOM · shares +1.6% · price −9.7% | 0.62% | $12.92B | −$1.36B | ||||||||
| Procter And Gamble CoCOM · shares +1.9% · price −13.7% | 0.62% | $12.89B | −$2.01B | ||||||||
| Home Depot IncCOM · shares +0.8% · price −6.0% | 0.62% | $12.88B | −$808.7M | ||||||||
| Citigroup IncCOM NEW · shares −1.4% · price −9.3% | 0.60% | $12.49B | −$1.28B | ||||||||
| Boeing CoCOM · shares −1.3% · price +11.2% | 0.55% | $11.49B | +$1.16B | ||||||||
| MastercardCL A · shares +1.9% · price +15.7% | 0.54% | $11.31B | +$1.51B | ||||||||
| Total · 4,974 positions | 100% | $2.09T | −$24.51B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q4 2017 to Q1 2018: 4,549 stocks held throughout, down $24.51B (−1.2%).
- Amazon+$6.82B+24%
- Microsoft+$2.83B+7%
- Netflix+$2.66B+54%
- Intel+$1.75B+13%
- Cisco+$1.54B+12%
- Procter And Gamble Co−$2.01B−14%
- General Electric Co−$2.11B−23%
- Exxon Mobil Corp−$2.33B−11%
- Wells Fargo Co New−$2.37B−14%
- Meta−$2.44B−9%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 6 splits read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 7, 2026 | $6.73T+18% | SEC ↗ |
| Q1 2026 | May 13, 2026 | $5.72T−3% | SEC ↗ |
| Q4 2025 | Feb 12, 2026 | $5.92T+4% | SEC ↗ |
| Q3 2025 | Nov 12, 2025 | $5.71T+9% | SEC ↗ |
| Q2 2025 | Aug 12, 2025 | $5.25T+10% | SEC ↗ |
| Q1 2025 | May 2, 2025 | $4.76T−4% | SEC ↗ |
| Q4 2024 | Feb 7, 2025 | $4.94T+4% | SEC ↗ |
| Q3 2024 | Nov 13, 2024 | $4.76T+8% | SEC ↗ |
| Q2 2024 | Aug 13, 2024 | $4.42T+3% | SEC ↗ |
| Q1 2024 | May 10, 2024 | $4.30T+10% | SEC ↗ |
| Q4 2023 | Feb 13, 2024 | $3.92T+13% | SEC ↗ |
| Q3 2023 | Nov 13, 2023 | $3.48T−4% | SEC ↗ |
| Q2 2023 | Aug 11, 2023 | $3.63T+7% | SEC ↗ |
| Q1 2023 | May 12, 2023 | $3.39T+6% | SEC ↗ |
| Q4 2022 | Feb 13, 2023 | $3.19T+9% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $2.94T−6% | SEC ↗ |
| Q2 2022 | Aug 12, 2022 | $3.12T−16% | SEC ↗ |
| Q1 2022 | May 12, 2022 | $3.71T−6% | SEC ↗ |
| Q4 2021 | Feb 10, 2022 (amended) | $3.93T+10% | SEC ↗ |
| Q3 2021 | Nov 9, 2021 | $3.57T−1% | SEC ↗ |
| Q2 2021 | Aug 11, 2021 | $3.59T+6% | SEC ↗ |
| Q1 2021 | May 7, 2021 | $3.40T+9% | SEC ↗ |
| Q4 2020 | Feb 5, 2021 | $3.13T+16% | SEC ↗ |
| Q3 2020 | Nov 6, 2020 | $2.71T+8% | SEC ↗ |
| Q2 2020 | Aug 14, 2020 | $2.51T+23% | SEC ↗ |
| Q1 2020 | May 1, 2020 | $2.04T−22% | SEC ↗ |
| Q4 2019 | Feb 13, 2020 | $2.61T+10% | SEC ↗ |
| Q3 2019 | Nov 8, 2019 | $2.38T+2% | SEC ↗ |
| Q2 2019 | Aug 22, 2019 (amended) | $2.34T+4% | SEC ↗ |
| Q1 2019 | May 9, 2019 | $2.24T+13% | SEC ↗ |
| Q4 2018 | Feb 8, 2019 | $1.98T−14% | SEC ↗ |
| Q3 2018 | Nov 9, 2018 | $2.31T+6% | SEC ↗ |
| Q2 2018 | Aug 9, 2018 | $2.17T+4% | SEC ↗ |
| Q1 2018 | May 9, 2018 | $2.09T−0% | SEC ↗ |
| Q4 2017 | Feb 9, 2018 | $2.10T+6% | SEC ↗ |
| Q3 2017 | Nov 14, 2017 | $1.98T+5% | SEC ↗ |
| Q2 2017 | Aug 10, 2017 | $1.89T+4% | SEC ↗ |
| Q1 2017 | May 12, 2017 | $1.82T+2,478% | SEC ↗ |
| Q4 2016 | Feb 10, 2017 | $70.66B+1% | SEC ↗ |
| Q3 2016 | Nov 8, 2016 | $69.66B+5% | SEC ↗ |
| Q2 2016 | Aug 10, 2016 | $66.46B+7% | SEC ↗ |
| Q1 2016 | May 10, 2016 | $62.17B | SEC ↗ |